Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

TAPAS

Home DrugsTAPAS

TAPAS

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

COMPOSITIONS AND METHODS TO TREAT CANCER WITH CUPREDOXINS AND CpG RICH DNA
Applicant: DAS GUPTA TAPASPriority: 2007
US
3 publications
Modified cupredoxin derived peptides
Applicant: DAS GUPTA TAPAS KPriority: 2009
US
2 publications
Topical compositions containing 5'-adenosine-diphosphate ribose
Applicant: DAS TAPASPriority: 2004
US
COMPOSITIONS AND METHODS TO PREVENT CANCER WITH CUPREDOXINS
Applicant: DAS GUPTA TAPASPriority: 2007
US
5 publications
Compositions and methods to concurrently treat or prevent multiple diseases with cupredoxins
Applicant: DAS GUPTA TAPASPriority: 2008
US
MODIFICATIONS OF CUPREDOXIN DERIVED PEPTIDES AND METHODS OF USE THEREOF
Applicant: DAS GUPTA TAPASPriority: 2007
US
2 publications
Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
Applicant: BEATTIE CRAIG WPriority: 2009
US
2 publications
NUTRITIONAL COMPOSITION COMPRISING CEREAL BETA-GLUCAN AND SALACIA EXTRACT
Applicant: DAS TAPASPriority: 2011
US